Financials
Income statement
| Fiscal date | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
|---|---|---|---|---|
| Total reported revenue | 17.0B | 15.7B | 16.7B | 15.1B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 5.9B | 5.5B | 6.0B | 5.4B |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 6.9B | 5.5B | 6.4B | 5.2B |
| Tax provision | 1.5B | 1.1B | 1.3B | 993M |
| Net income | 5.4B | 4.4B | 5.1B | 4.2B |
| Basic EPS | 3.8 | 3.0 | 3.5 | — |
| Diluted EPS | 3.8 | 3.0 | 3.5 | — |
| Basic average shares | 1.4B | 1.4B | 1.4B | — |
| Diluted average shares | 1.4B | 1.4B | 1.4B | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 5.4B | 4.4B | 5.1B | 4.2B |
| Minority interests | 1M | -4M | -2M | -3M |
| Preferred stock dividends | — | — | — | — |